Fourteen-Year Anti-TNF Therapy in Crohn’s Disease Patients: Clinical Characteristics and Predictive Factors

被引：0
|
作者：
Aisaku Osamura
Yasuo Suzuki
机构：
[1] Toho University,Department of Internal Medicine, Sakura Medical Center
来源：
Digestive Diseases and Sciences | 2018年 / 63卷
关键词：
Crohn’s disease; Loss of response; Infliximab; Adalimumab; Risk factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：204 / 208
页数：4
相关论文
共 50 条
  • [1] Fourteen-Year Anti-TNF Therapy in Crohn's Disease Patients: Clinical Characteristics and Predictive Factors
    Osamura, Aisaku
    Suzuki, Yasuo
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (01) : 204 - 208
  • [2] PREDICTIVE FACTORS FOR LOSS OF RESPONSE TO ANTI-TNF IN CROHN'S DISEASE
    Moreira dos Santos, Byanca Rossetti
    Marques dos Santos, Carlos Henrique
    Moreira dos Santos, Vitoria Rossetti
    Garcia Torrez, Claudia Yanina
    Palomares-Junior, Daniel
    ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2020, 33 (02):
  • [3] Anti-TNF therapy for Crohn's disease
    D'Haens, G
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (04) : 289 - 294
  • [4] Practical Application of Anti-TNF Therapy for Luminal Crohn's Disease
    Kamm, Michael A.
    Ng, Siew C.
    De Cruz, Peter
    Allen, Patrick
    Hanauer, Stephen B.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (11) : 2366 - 2391
  • [5] Anti-TNF Therapy in Crohn's Disease
    Adegbola, Samuel O.
    Sahnan, Kapil
    Warusavitarne, Janindra
    Hart, Ailsa
    Tozer, Philip
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (08)
  • [6] Atypical mycobacteria: showerheads, anti-TNF therapy and Crohn's disease
    Desai, Alka A.
    Marks, Daniel J. B.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (05) : 695 - 699
  • [7] Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease
    Chaparro, Maria
    Aterido, Adria
    Guerra, Ivan
    Iborra, Marisa
    Luis Cabriada, Jose
    Bujanda, Luis
    Taxonera, Carlos
    Garcia-Sanchez, Valle
    Marin-Jimenez, Ignacio
    Barreiro-de Acosta, Manuel
    Vera, Isabel
    Dolores Martin-Arranz, Maria
    Hernandez-Breijo, Borja
    Mesonero, Francisco
    Sempere, Laura
    Gomollon, Fernando
    Hinojosa, Joaquin
    Bermejo, Fernando
    Beltran, Belen
    Rodriguez-Pescador, Ainhoa
    Maria Banales, Jesus
    Olivares, David
    Aguilar-Melero, Patricia
    Menchen, Luis
    Ferreiro-Iglesias, Rocio
    Blazquez Gomez, Isabel
    Benitez Garcia, Beatriz
    Guijarro, Luis G.
    Marin, Alicia C.
    Bernardo, David
    Marsal, Sara
    Julia, Antonio
    Gisbert, Javier P.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
  • [8] Anti-TNF Therapy Is Associated with Decreased Imaging and Radiation Exposure in Patients with Crohn's Disease
    Patil, Seema A.
    Rustgi, Ankur
    Quezada, Sandra M.
    Flasar, Mark H.
    Vandermeer, Fauzia
    Cross, Raymond K.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (01) : 92 - 98
  • [9] Association of serum VEGF with clinical response to anti-TNFα therapy for Crohn's disease
    Eder, Piotr
    Korybalska, Katarzyna
    Lykowska-Szuber, Liliana
    Krela-Kazmierczak, Iwona
    Stawczyk-Eder, Kamila
    Klimczak, Katarzyna
    Szymczak, Aleksandra
    Linke, Krzysztof
    Witowski, Janusz
    CYTOKINE, 2015, 76 (02) : 288 - 293
  • [10] Anti-TNF and Fistulising Perianal Crohn's Disease: Use in Clinical Practice
    Bourikas, Leonidas A.
    Koutroubakis, Ioannis E.
    CURRENT DRUG TARGETS, 2010, 11 (02) : 187 - 197
12345